Imipramine for Breast Cancer

"This clinical trial is currently not enrolling any patients. It was initially posted on July 5th 2019 and its information was last updated on September 10th 2022. Those seeking other trials may do so, as there are presently 2602 studies searching for participants with breast cancer and 2 investigations into Imipramine in progress."

"This clinical trial is no longer recruiting patients; it was initially posted on July 5th 2019 and the most recent update occured on September 10th 2022. Those looking for other studies may consider checking out 2602 trials actively enrolling participants with breast cancer or 2 Imipramine related medical trials that are currently accepting individuals."

"Imipramine is a successful method of addressing neuropathic pain, depression, and bulimia nervosa in certain patients."

"This research project is seeking to enrol 17 individuals, ranging between 18 and 71 years old, who have been diagnosed with breast cancer. In order for potential participants to be eligible they must possess an ECOG Performance status of 0, 1 or 2; provide a complete physical examination within the last month; not suffer from any gastrointestinal issues that would compromise their absorption rate; exhibit no prior history of unrelated breast cancer and show capability when it comes to taking oral medications."

"To be eligible for this clinical trial, patients must range from 18 to 71 years old. For younger individuals (under the age of 18), there are 75 studies and 2509 studies for senior citizens (over 65)."

"At present, there are 2 clinical trials assessing the efficacy of Imipramine. None have progressed to Phase 3 yet; however, most studies take place in San Antonio with a couple elsewhere."